Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,586 INR | +1.16% | +4.54% | +0.32% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.32% | 2.55B | |
-20.98% | 8.01B | |
+67.01% | 4.3B | |
-8.93% | 2.46B | |
-38.69% | 2.44B | |
-10.75% | 1.89B | |
-19.84% | 1.59B | |
-40.24% | 1.21B | |
+16.56% | 1.17B | |
+15.58% | 966M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024